[1]BioorganicandMedicinalChemistryLetters,2014,vol.24,p.3521-3525
[2]Patent:US2012/149718,2012,A1.Locationinpatent:Page/Pagecolumn43
1682-39-9
4570-41-6
1339452-03-7
1545756-38-4
1806424-25-8
1267419-78-2
36798-25-1 | (2-Methyl-1h-indol-5-yl)methylamine | AA0077UK | MFCD05864579
36755-02-9 | Methyl 3-(chloromethyl)-4-methoxybenzoate | AA00789E | MFCD05864592
36646-13-6 | 2-Benzyl-5-(chloromethyl)-1,3,4-oxadiazole | AA0078PR | MFCD09041568
375-45-1 | 1,2,3,4-Tetrachlorohexafluorobutane | AA0079FB | MFCD00040135
383-23-3 | 4-(4-Fluorophenylsulfonyl)morpholine | AA0079ZG | MFCD00194713
111466-63-8 | (S,R,S,S)-Orlistat | AA007AHC | MFCD23160335
1070892-04-4 | 5-Bromo-2-(trifluoromethyl)isonicotinonitrile | AA007B33 | MFCD18261445
108958-36-7 | 2-(3-Methoxy-benzyl)-piperidine | AA007BL0 | MFCD02663630
106582-41-6 | 7-Chloro-2,4-bis(trifluoromethyl)[1,8]naphthyridine | AA007C7P | MFCD00140156
33646-31-0 | Methyl 2-amino-3-chloropropanoate hydrochloride | AA007CRX | MFCD00038914